Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Sanofi - pharmaceutical segment revenues by product group 2015-2018

Revenue of Sanofi's pharmaceutical segment by product group from 2015 to 2018 (in million euros)

by Matej Mikulic, last edited Mar 11, 2019
Sanofi - pharmaceutical segment revenues by product group 2015-2018 This statistic shows the revenue of Sanofi's pharmaceutical segment by product groups from 2015 to 2018. In 2018, Sanofi's pharmaceutical group generated 1.49 billion euros in revenue oncology products. Sanofi is one of the top global pharmaceutical companies. It is headquartered in Paris, France.
Sanofi's segments

Sanofi’s pharmaceutical segment generated 5.5 billion euros in revenue through its diabetes product group in 2018, a decrease compared to 7.6 billion euros in 2015. Lantus is one of Sanofi’s best selling pharmaceutical products. Its revenue has risen from 2.4 billion euros in 2008 to 6.39 billion euros in 2015, but decreased to 3.6 billion in 2018. Lantus is an insulin glargine used daily to control blood sugar levels of patients with diabetes. Clopidogrel, which is marketed under Sanofi’s trade name Plavix, generated 1.44 billion euros in 2018. Plavix is an oral agent that prevents blood clots in patients with some types of heart disease and also prevents heart attacks.

Among its vaccination segment, Sanofi has several profitable products. The company’s influenza vaccines generated over 1.7 billion euros in 2018. Fluzone is a marketed brand of Sanofi’s influenza vaccine, of which varieties exist to target persons of certain age groups.

Sanofi originated in 1973 as a subsidiary of Elf Aquitaine, the company ventured into the U.S. market in 1994. Although, the company is primarily focused on the pharmaceutical market, it also maintains an animal health segment. This segment develops products in four groups including antiparasitics and antiinfectives. Sanofi generated some 34.5 billion euros in total revenues in 2018. The company expended approximately 5.9 billion euros the same year on research and development ventures.
Show more

Revenue of Sanofi's pharmaceutical segment by product group from 2015 to 2018 (in million euros)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format

All Information
in one Presentation


Everything On "Sanofi" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Sanofi"
  • Global positioning
  • Overview
  • Revenue distribution
  • Company shares
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.